Piper Sandler lowered the firm’s price target on CVS Health to $82 from $85 and keeps an Overweight rating on the shares. The analyst updated the company’s model to reflect the Q2 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CVS:
- CVS Health management to meet with Mizuho
- Walmart asks pharmacists to take voluntarily wage cuts, Reuters says
- CVS Health (NYSE:CVS) Stock: 3 Reasons Why It’s as Attractive as Ever
- Jefferies healthcare analysts to hold an analyst/industry conference call
- CVS Unveils Cordavis to Offer Biosimilars. Should AbbVie (NYSE:ABBV) Worry?